Skip to content

Effects of a-lipoic acid on sperm quality in patients with varicocele-related male infertility

Effects of a-lipoic acid on sperm quality in patients with varicocele-related male infertility

Status
Recruiting
Phases
Early Phase 1
Study type
Interventional
Source
ChiCTR
Registry ID
ChiCTR2100054958
Enrollment
Unknown
Registered
2021-12-29
Start date
2021-12-30
Completion date
Unknown
Last updated
2023-01-09

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Male infertility

Interventions

Operation group - observation group:Surgery + lipoic acid
Operation group - control group:Surgery + Vitamin E
Non-surgical group-observation group:Lipoic acid
Non-surgical group-control group:Vitamin E

Sponsors

Guilin People's Hospital
Lead Sponsor

Eligibility

Sex/Gender
Male
Age
23 Years to 50 Years

Inclusion criteria

Inclusion criteria: 1. Male infertile patients aged 23-50 years. 2. Abnormal semen quality. 3. The woman has normal fertility, or suffers from infertility-related diseases, but may be cured. 4. Primary varicocele, physical examination of varicocele II degree (palpable in standing position) or III degree (no palpation visible), color Doppler ultrasound measures spermatic vein diameter (DR) >= 2.8 mm in calm breathing, and blood reflux duration (TR) >= 4 seconds during Valsalva maneuvers.

Exclusion criteria

Exclusion criteria: 1. Those with organic diseases of pituitary or testis, epididymis and vas deferens. 2. Azoospermia or chromosomal abnormalities. 3. Those with a history of vas deferens surgery or spermatic obstruction that cannot be ruled out. 4. Reproductive system infection. 5. Severe erectile dysfunction or ejaculation disorder. 6. Secondary varicocele. 7. Those who have received VC surgery. 8. Abdominal infection and history of open pelvic surgery lead to extensive adhesions. 9. Patients with a history of tumor, diabetes or combined with severe heart, liver, kidney, hematopoietic system diseases. 10. Patients with severe mental illness. 11. Participating in other clinical trials at the same time or using drugs that improve sperm quality or affect VC in the past 3 months.

Design outcomes

Primary

MeasureTime frame
Sperm parameters;Sex hormone;Testicular volume;Sperm DNA fragment index;

Countries

China

Contacts

Public ContactZhang Qifeng

Guilin People's Hospital

lanwind@163.com+86 15107733166

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Feb 12, 2026